Media framing xylazine as a “zombie drug” is amplifying stigma onto people who use drugs

Commentary
by
Bowles, Jeannette M., Elizabeth C. Copulsky & Megan K. Reed

Release Date

2024

Geography

North America

Language of Resource

English

Full Text Available

No

Open Access / OK to Reproduce

No

Peer Reviewed

Yes

Findings/Key points

People who use drugs are often reluctant to seek medical care due to experiences of medically-institutionalized stigma. Based on the media's extensive depiction of xylazine as the “zombie drug,” it is plausible that medical practitioners have been exposed to this stigmatizing framing, which could unknowingly detrimentally impact provision of medical care. Strategies to offset harms of xylazine-associated stigmas are proposed, including that medical practitioners undergo evidence-based training to reduce stigmatizing responses to severe xylazine-associated ulcers as any indication of enacted stigma can be internalized by the person seeking treatment, which in turn can perpetuate harms like sepsis or overdose.

Keywords

About prescribers
Stigma